Executive summary of the KDIGO 2022 Clinical Practice Guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis c in chronic kidney disease

Martin, Paul and Awan, Ahmed A. and Berenguer, Marina C. and Bruchfeld, Annette and Fabrizi, Fabrizio and Goldberg, David S. and Jia, Jidong and Kamar, Nassim and Mohamed, Rosmawati and Pessoa, Mario Guimaraes and Pol, Stanislas and Sise, Meghan E. and Balk, Ethan M. and Gordon, Craig E. and Adam, Gaelen and Cheung, Michael and Earley, Amy and Jadoul, Michel (2022) Executive summary of the KDIGO 2022 Clinical Practice Guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis c in chronic kidney disease. Kidney International, 102 (6). pp. 1228-1237. ISSN 1523-1755, DOI https://doi.org/10.1016/j.kint.2022.07.012.

Full text not available from this repository.
Official URL: https://doi.org/10.1016/j.kint.2022.07.012

Abstract

Infection with the hepatitis C virus (HCV) has adverse liver, kidney, and cardiovascular consequences in patients with chronic kidney disease (CKD), including those on dialysis therapy or with a kidney transplant. Since the publication of the Kidney Disease: Improving Global Outcomes (KDIGO) HCV Guideline in 2018, advances in HCV management, particularly in the field of antiviral therapy and treatment of HCV-associated glomerular diseases, coupled with increased usage of HCV-positive kidney grafts, have prompted a reexamination of the 2018 guideline. As a result, the Work Group performed a comprehensive review and revised the 2018 guidance. This Executive Summary highlights key aspects of the updated guideline recommendations for 3 chapters: Chapter 2: Treatment of HCV infection in patients with CKD; Chapter 4: Management of HCV-infected patients before and after kidney transplantation; and Chapter 5: Diagnosis and management of kidney diseases associated with HCV infection.

Item Type: Article
Funders: KDIGO
Uncontrolled Keywords: chronic kidney disease; cryoglobulinemia; dialysis; direct-acting antivirals; glomerular diseases; guideline; hemodialysis; hepatitis C virus; infection control; KDIGO; kidney transplantation; liver testing; nosocomial transmission; screening; systematic review
Subjects: R Medicine > RC Internal medicine
Divisions: Faculty of Medicine > Medicine Department
Depositing User: Ms Koh Ai Peng
Date Deposited: 28 Oct 2024 07:21
Last Modified: 28 Oct 2024 07:40
URI: http://eprints.um.edu.my/id/eprint/46166

Actions (login required)

View Item View Item